共 51 条
[1]
Holzgreve H(1993)Treatment of hypertension in the elderly Drugs 46 24-31
[2]
Middeke M(1999)1999 World Health Organization — International Society of Hypertension Guidelines for the Management of Hypertension J Hypertens 17 151-83
[3]
Elmfeldt D(1997)Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effect J Hum Hypertens 11 S49-53
[4]
George M(1999)A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study Am J Hypertens 12 1181-7
[5]
Hübner R(2000)The past, present and future of hypertension management: a potential role for AT J Renin Angiotensin Aldo System 1 5-10
[6]
Lacourcière Y(1996)-receptor antagonists Am J Med 101 83S-92S
[7]
Asmar R f t(1995)Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics Drug Saf 12 161-7
[8]
Hollenberg NK(1991)Metabolic adverse reactions to diuretics: clinical relevance to elderly patients Lancet 338 1281-5
[9]
Sever PS(1991)Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) JAMA 265 3255-64
[10]
Weir MR(1992)Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) BMJ 304 405-12